NCT07577323尚未招募不适用
Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential Hypertension: A Prospective, Double-blind, Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
The primary objective of this research is to study the efficacy and safety of temporal interference stimulation for blood pressure modulation in patients with mild essential hypertension.
详细描述
This project aims to include 60 participants, who are randomly assigned in a 1 ratio into two groups named TI group and sham TI group , and evaluate the effectiveness and safety of temporal interference stimulation in patients with mild essential hypertension and through A prospective, double-blind, randomized controlled clinical trial. It is expected to provide new therapeutic options for patients with mild essential hypertension with alternative treatment options.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 30 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged between 30 and 65 years old.
- •Office blood pressure with systolic blood pressure (SBP) 140-159 mmHg and/or diastolic blood pressure (DBP) 90-99 mmHg.
- •No intake of any antihypertensive drugs or have discontinued antihypertensive medication for at least 3 months prior to randomization; no intention to receive any other antihypertensive therapy within the 15-week study period.
- •Written informed consent has been obtained from the subject or their legally authorized representative after being informed of the potential risks.
排除标准
- •Known or suspected secondary hypertension.
- •Contraindications to TI treatment or sham TI treatment, including intracranial metal implants (e.g., pacemaker, ventriculoperitoneal shunt, vascular clip), craniocerebral surgery within the last 6 months, history of intracranial tumor or hemorrhage; skin damage, infection, eczema or allergy at the stimulation site (frontal/temporal region); severe skin diseases (e.g., psoriasis).
- •Subjects with high risk of cerebrovascular disease indicated by cranial magnetic resonance imaging.
- •History of myocardial infarction or cerebral infarction.
- •Atrial fibrillation or other severe arrhythmias, such as severe bradycardia, third-degree atrioventricular block, or ventricular tachycardia.
- •Severe or unstable medical conditions, including severe hepatic dysfunction (defined as alanine transaminase or aspartate transaminase level more than 2 times the upper limit of normal), severe renal dysfunction (defined as serum creatinine level more than 1.5 times the upper limit of normal), and severe heart failure (New York Heart Association Class III and IV).
- •Females who are pregnant, breastfeeding, or planning to become pregnant within one year.
- •Individuals unable to cooperate due to mental illness or other reasons.
- •Participants enrolled in other clinical trials within 3 months prior to randomization.
- •Participants deemed ineligible for this trial for other reasons determined by the investigator.
研究者
Liankun_Ren
Professor
Xuanwu Hospital, Beijing
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative DiseasesNCT07449117Masaryk University70
尚未招募
不适用
Study on the Efficacy of Temporal Interference Stimulation (TIS) for Parkinson's DiseaseParkinson's DiseaseNCT07312279Zhongnan Hospital24
已完成
不适用
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's DiseaseNCT07572903The First Affiliated Hospital of Anhui Medical University96
尚未招募
不适用
Lily's Grace Temporal InterferenceEpilepsyNCT07520955University of Wisconsin, Madison24
招募中
不适用
Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.2NCT07339072Indiana University30